Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the structure of the gut microbiota in patients with colorectal cancer (CRC) compared with healthy controls, using pyrosequencing-based analysis of 16S rRNA genes. The researchers separately characterized microbiota from the intestinal lumen, cancerous tissue, and matched noncancerous normal tissue. They also examined mucosa-adherent microbial composition using rectal swab samples, since tissue-adherent bacterial communities can be altered by bowel cleansing prior to biopsy.
Who was studied?
The study population consisted of patients diagnosed with colorectal cancer, whose intestinal lumen, tumor tissue, and adjacent noncancerous tissue samples were compared against matched microbiota from healthy individuals. Rectal swab samples were used specifically to capture mucosa-adherent bacteria in these patients. The abstract does not provide a specific sample size or demographic details for the cohort.
What were the most important findings?
The microbial structure of the intestinal lumen differed significantly from that of cancerous tissue, with the lumen showing greater abundance of Firmicutes and lower abundance of Bacteroidetes and Proteobacteria, along with more phylotypes associated with energy harvest and host metabolic exchange. Cancerous and noncancerous tissue had broadly similar overall microbial structures, but tumor tissue showed lower microbial diversity. Both the intestinal lumen microbiota and the mucosa-adherent microbiota differed in CRC patients compared to matched microbiota in healthy individuals, and Lactobacillales was enriched in cancerous tissue.
What are the greatest implications of this study?
By distinguishing luminal, tumor, and mucosa-adherent microbial communities, the findings suggest that CRC is associated with site-specific shifts in gut microbiota rather than a single uniform dysbiosis pattern. The reduced diversity in tumor tissue and altered mucosa-adherent communities point to a tumor microenvironment that selects for or is shaped by particular bacterial taxa. These distinctions underscore the importance of sampling method and anatomical site when investigating microbiota-CRC relationships in future research.